Natixis’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.6M Buy
314,383
+84,139
+37% +$6.58M 0.11% 119
2025
Q1
$16.6M Sell
230,244
-15,967
-6% -$1.15M 0.09% 155
2024
Q4
$18.2M Buy
246,211
+112,637
+84% +$8.34M 0.11% 135
2024
Q3
$8.81M Sell
133,574
-262,631
-66% -$17.3M 0.05% 230
2024
Q2
$36.6M Buy
396,205
+293,904
+287% +$27.1M 0.21% 78
2024
Q1
$9.78M Sell
102,301
-96,945
-49% -$9.26M 0.05% 228
2023
Q4
$15.2M Sell
199,246
-358,814
-64% -$27.4M 0.11% 150
2023
Q3
$38.7M Buy
558,060
+275,029
+97% +$19.1M 0.3% 71
2023
Q2
$26.7M Buy
283,031
+222,318
+366% +$21M 0.22% 92
2023
Q1
$5.02M Sell
60,713
-102,984
-63% -$8.52M 0.05% 264
2022
Q4
$12.2M Buy
163,697
+7,121
+5% +$531K 0.07% 229
2022
Q3
$13.1M Buy
156,576
+106,122
+210% +$8.87M 0.06% 226
2022
Q2
$4.8M Sell
50,454
-42,180
-46% -$4.01M 0.02% 440
2022
Q1
$10.9M Buy
92,634
+72,397
+358% +$8.52M 0.04% 402
2021
Q4
$2.62M Sell
20,237
-9,681
-32% -$1.25M 0.01% 704
2021
Q3
$3.39M Sell
29,918
-10,277
-26% -$1.16M 0.01% 627
2021
Q2
$4.16M Sell
40,195
-75,721
-65% -$7.84M 0.02% 415
2021
Q1
$9.7M Sell
115,916
-8,171
-7% -$683K 0.03% 383
2020
Q4
$11.3M Buy
+124,087
New +$11.3M 0.04% 363
2020
Q3
Sell
-22,377
Closed -$1.55M 799
2020
Q2
$1.55M Sell
22,377
-100,716
-82% -$6.96M 0.01% 459
2020
Q1
$7.74M Buy
123,093
+71,547
+139% +$4.5M 0.06% 222
2019
Q4
$3.99M Sell
51,546
-179,148
-78% -$13.9M 0.02% 446
2019
Q3
$16.9M Buy
+230,694
New +$16.9M 0.11% 181
2018
Q3
Sell
-102,705
Closed -$4.98M 864
2018
Q2
$4.98M Sell
102,705
-9,633
-9% -$467K 0.03% 382
2018
Q1
$5.22M Buy
112,338
+65,199
+138% +$3.03M 0.03% 356
2017
Q4
$1.77M Sell
47,139
-52,173
-53% -$1.96M 0.01% 429
2017
Q3
$3.62M Buy
+99,312
New +$3.62M 0.03% 322
2017
Q2
Sell
-13,125
Closed -$412K 868
2017
Q1
$412K Buy
+13,125
New +$412K 0.01% 568
2015
Q2
Sell
-29,586
Closed -$702K 395
2015
Q1
$702K Buy
+29,586
New +$702K 0.01% 272